logo

Press Releases
Share

Invitation - Orexo Digital Therapeutics business update October 1

9/25 08:20 AM ET

Biovica completes 510(k) submission for DiviTum®TKa to the FDA

9/25 08:11 AM ET

FDA Approves Bausch + Lomb Alaway® Preservative Free (Ketotifen Fumarate) Ophthalmic Solution, 0.035%

9/25 08:00 AM ET

Changes to Calfrac Management Transaction Fall Woefully Short of Shareholder Recoveries Under Wilks Premium Offer

9/25 06:00 AM ET

Mirati Therapeutics Presents Phase 2 Data On Sitravatinib In Combination With Nivolumab In Urothelial Cancer At ESMO Virtual Congress

9/18 08:00 AM ET

Predictiv AI Inc. and Sigfox Canada Agree to Enter into Global Sales Channel and Technology Integration Partnership for ThermalPass

9/18 07:47 AM ET

Alkermes Presents New Clinical Data on ALKS 4230 in Mini Oral Presentation at 2020 European Society for Medical Oncology (ESMO) Virtual Congress

9/18 06:30 AM ET

58.com Announces Completion of Merger

9/18 03:30 AM ET

Alzinova carries out a 95 percent guaranteed rights issue of units of approximately SEK 50 million to finance the clinical development of ALZ-101

9/18 03:02 AM ET

1933 Industries Signs Distribution Deal with CBD Plus to Carry Canna Hemp™ Products in over 120 Stores

9/11 08:30 AM ET

Atlas Corp. Announces Departure of Chief Financial Officer

9/11 07:00 AM ET

Canadian Solar Prices Offering of US$200 Million Convertible Senior Notes

9/11 07:00 AM ET

Immunic, Inc. Publishes Full Unblinded Clinical Data From Phase 2 EMPhASIS Trial of IMU-838 in Patients With Relapsing-Remitting Multiple Sclerosis and Announces Poster Presentation at the MSVirtual2020

9/11 06:30 AM ET

U.S. Concrete Launches Proposed $300 Million Senior Notes Offering

9/08 08:23 AM ET

Biocept Executes In-Network Provider Agreement with Health Net Federal Services Extending Coverage for its Liquid Biopsy Oncology Platform to the TRICARE West Region Network

9/08 08:00 AM ET

Switch Announces $500 Million Offering of Senior Notes

9/08 07:45 AM ET

Compugen Doses First Patient in Phase 1/2 Triple Combination Study of COM701 with Bristol Myers Squibb's Opdivo® and Anti-TIGIT Antibody

9/08 07:00 AM ET

Liminal BioSciences Announces Resubmission of Biologics License Application to U.S. Food and Drug Administration for Ryplazim® (plasminogen) for Treatment of Congenital Plasminogen Deficiency

9/08 06:00 AM ET

Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

9/04 08:00 AM ET

Yum China Announces Pricing of Global Offering

9/04 07:15 AM ET

Sasol invites interested parties to partner for the development of CO2 utilisation technologies at its SA operations

9/04 07:05 AM ET

I-Mab Announces $418 Million Private Placement with Hillhouse Capital-Led Consortium

9/04 07:01 AM ET

VistaGen Reports Positive New Data from Second Preclinical Study of AV-101 in Combination with Probenecid

9/03 08:30 AM ET

Greenhouse To Open Flagship Dispensary in Skokie, IL

9/03 08:23 AM ET

Multi-site study to evaluate the role of testing guidelines in ensuring access to genetic information for men with prostate cancer

9/03 07:30 AM ET

Akebia Therapeutics Announces Top-Line Results from its PRO2TECT Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients Not on Dialysis

9/03 07:00 AM ET

Signet Jewelers Reports Q2 Results And Accelerated Sales Momentum

9/03 06:50 AM ET

Melody Investment Advisors Acquires CTI Towers

9/01 08:30 AM ET

Fuling Global Enters into Definitive Merger Agreement for Going Private Transaction

9/01 08:00 AM ET

The Very Good Food Company Announces Q2 Financial Results

9/01 08:00 AM ET
Previous 30 Stories
Follow RTT
Copyright © 2020 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap